Skip to content

Effect of Minocycline gel Vs Benzoyl Peroxide gel in the treatment of Moderate Acne Vulgaris

A Comparative Study of Minocycline gel with Benzoyl Peroxide gel in the treatment of Moderate Acne Vulgaris In Adult Population Attending A Tertiary Care Centre - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072117
Enrollment
40
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Minocycline: 4% gel applied topically over lesions of acne vulgaris once daily for the period of 12 weeks Control Intervention1: Benzoyl Peroxide: 5% gel applied topically over lesions

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18-35 years of either gender. Females of reproductive age group will be included only if they are not planning to conceive till the end of the study. 2. Patients diagnosed with grade 1 and 2 Acne vulgaris according to acne grading criteria of Indian Association of Dermatologists, Venereologists and Leprologists (IADVL). 3. Patients willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. H/o hypersensitivity to any drugs. 2. Patients having any history of medical condition considered significant by the investigator. 3. Use of systemic antibiotics and steroids in the last month prior to the study.

Design outcomes

Primary

MeasureTime frame
1.To compare the mean change in the Investigators Global Assessment (IGA) score for Acne from the baseline to 12 weeks in two treatment armsTimepoint: baseline,4 weeks, 8 weeks, 12 weeks

Secondary

MeasureTime frame
1.Change in quality of life using Cardiff Acne Disability Index (CADI). from baseline to 12 weeks in two treatment arms. 2.Incidence of adverse effects in two treatment arms. Timepoint: Baseline,4 weeks, 8 weeks, 12 weeks

Countries

India

Contacts

Public ContactDr M Padmaja

Nizams Institute of Medical Sciences

gobiat28@gmail.com8667355827

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026